Back
Xenetic Biosciences, Inc. 10K Form
Sell
41
XBIO
Xenetic Biosciences, Inc.
Last Price:
$2.54
Seasonality Move:
22.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive XBIO News And Ratings
See the #1 stock for the next 7 days that we like better than XBIO
XBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $2.5M |
|---|---|
| Cash Flow: | $-658.2K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.56 |
| Price / Book: | 1.4 |
Profitability
| EPS (TTM): | -2.04670 |
|---|---|
| Net Income (TTM): | $-3.2M |
| Gross Margin: | $0 |
| Return on Equity: | -59.39% |
| Return on Assets: | -50.65% |
Xenetic Biosciences, Inc. Earnings Forecast
Key Xenetic Biosciences, Inc. Financial Ratios
-
The Gross Profit Margin over the past 11 years for XBIO is 0.00%.
-
The Selling, General & Administrative Expenses for XBIO have been equal to 136.64% of Gross Profit Margin.
-
The Research & Development expenses have been 103.34% of Revenue.
-
The Net Earning history of XBIO is -158.39% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 9 years.
Xenetic Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XBIO |
| CUSIP: | 984015 |
| Website: | xeneticbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.56 |
| Quick Ratio: | 3.71 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XBIO Technical Analysis vs Fundamental Analysis
Sell
41
Xenetic Biosciences, Inc. (XBIO)
is a Sell
Is Xenetic Biosciences, Inc. a Buy or a Sell?
-
Xenetic Biosciences, Inc. stock is rated a SellThe current Xenetic Biosciences, Inc. [XBIO] share price is $2.42. The Score for XBIO is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.